LAWRENCEVILLE, NJ--(Marketwire - February 06, 2012) - Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that Michael H. Tardugno, Celsion's President and Chief Executive Officer, will be presenting at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on Monday, February 13 at 9:00 A.M. Eastern Time at the Waldorf=Astoria Hotel in New York City.
A live webcast of the presentation will be available on Celsion's website at http://www.celsion.com/events.cfm. The webcast will be archived on the same site for replay following the conference.
About Celsion Corporation
Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, and the North Shore Long Island Jewish Health System.
For more information on Celsion, visit our website: http://www.celsion.com.